Elisabeth zkh

Tilburg 5022 GC

0 studies enrolling now · 1 studies all time

What they study most

Leukemia, Lymphocytic, Chronic, B-Cell

Studies at this site

• A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling